TriSalus Life Sciences (TLSI) Income from Continuing Operations (2021 - 2026)
TriSalus Life Sciences posted quarterly Income from Continuing Operations of 1539000.0 for Q1 2026, up 114.83% year-on-year from 716367.94 in Q1 2025, and up 115.78% on a QoQ basis from 9753000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) has 6 years of Income from Continuing Operations data on file, last reported at 1539000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 114.83% year-over-year to 1539000.0; the trailing twelve-month figure through Mar 2026 stood at 27313000.0 (changed 0.36% YoY), and the FY2025 full-year result was 39227000.0, down 30.56% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1539000.0, up from 9753000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2836725.0 in Q1 2022 and bottomed at 35639000.0 in Q4 2023.
- The 5-year median for Income from Continuing Operations is 8288000.0 (2025), against an average of 8967708.0.
- Peak annual rise in Income from Continuing Operations reached 1137.69% in 2022, while the deepest fall reached 878.46% in 2022.
- A 5-year view of Income from Continuing Operations shows it stood at 22542000.0 in 2022, then slumped by 58.1% to 35639000.0 in 2023, then jumped by 71.64% to 10108000.0 in 2024, then advanced by 3.51% to 9753000.0 in 2025, then soared by 115.78% to 1539000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1539000.0 (Q1 2026), 9753000.0 (Q4 2025), and 10811000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -9.75 Mn |
| Sep 30, 2025 | -10.81 Mn |
| Jun 30, 2025 | -8.29 Mn |
| Mar 31, 2025 | -10.38 Mn |
| Dec 31, 2024 | -10.11 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -13.21 Mn |
| Dec 31, 2023 | -35.64 Mn |
| Sep 30, 2023 | -1.43 Mn |
| Jun 30, 2023 | -13.97 Mn |
| Mar 31, 2023 | -8.27 Mn |
| Dec 31, 2022 | -22.54 Mn |
| Sep 30, 2022 | -8.09 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.84 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 1.86 Mn |
| Jun 30, 2021 | 378,866.00 |
| Mar 31, 2021 | -273,368.00 |